NT-proBNP: A marker of preclinical cardiac damage in arterial hypertension
- 1 May 2011
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (11-12) , 1106-1111
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of University and Research
This publication has 35 references indexed in Scilit:
- Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart DiseaseJACC, 2006
- B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients With CKD: Relationship to Renal Function and Left Ventricular HypertrophyAmerican Journal of Kidney Diseases, 2005
- BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular DiseasesCongestive Heart Failure, 2004
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Left Ventricular Hypertrophy as A Surrogate End-Point in HypertensionClinical and Experimental Hypertension, 1999
- Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.Circulation, 1993
- Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertensionJACC, 1992
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential HypertensionAnnals of Internal Medicine, 1991
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986